Clinical trial
Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head
NCT00490360 · University of Zurich, Other · Completed
Key facts
| NCT number | NCT00490360 |
|---|---|
| Title | Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head |
| Official title | Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head |
| Lead sponsor | University of Zurich, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer of the Pancreatic Head |
| Intervention type | Drug |
| Interventions | Gemcitabine / Cisplatin |
| Enrollment | 2,007 |
| Start date | Oct 1, 2001 |
| Completion | May 1, 2007 |
| First posted | Jun 22, 2007 |
| Last update posted | Jun 22, 2007 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: